Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
High Prevalence of Tert Promoter Mutations in Micropapillary Urothelial Carcinoma Publisher Pubmed



Nguyen D1 ; Taheri D1, 5 ; Springer S3, 4 ; Cowan M1 ; Guner G1 ; Mendoza Rodriguez MA1 ; Wang Y4 ; Kinde I4 ; Vandenbussche CJ1 ; Olson MT1 ; Ricardo BFP1 ; Cunha I6 ; Fujita K7 ; Ertoy D8 Show All Authors
Authors
  1. Nguyen D1
  2. Taheri D1, 5
  3. Springer S3, 4
  4. Cowan M1
  5. Guner G1
  6. Mendoza Rodriguez MA1
  7. Wang Y4
  8. Kinde I4
  9. Vandenbussche CJ1
  10. Olson MT1
  11. Ricardo BFP1
  12. Cunha I6
  13. Fujita K7
  14. Ertoy D8
  15. Kinzler KW3, 4
  16. Bivalacqua TJ2
  17. Papadopoulos N3, 4
  18. Vogelstein B3, 4
  19. Netto GJ1, 2, 9
Show Affiliations
Authors Affiliations
  1. 1. Department of Pathology, Johns Hopkins University, Baltimore, 21287, MD, United States
  2. 2. Department of Urology, Johns Hopkins University, Baltimore, 21287, MD, United States
  3. 3. Department of Oncology, Johns Hopkins University, Baltimore, 21287, MD, United States
  4. 4. The Ludwig Center for Cancer Genetics and Therapeutics and Sidney Kimmel Comprehensive Cancer Center, Baltimore, 21231, MD, United States
  5. 5. Department of Pathology, Isfahan University of Medical Sciences, Isfahan Kidney Diseases Research Center, Isfahan, Iran
  6. 6. AC Camargo Cancer Centre, Sao Paulo, Brazil
  7. 7. Department of Urology, Osaka University, Osaka, Japan
  8. 8. Department of Pathology, Hacettepe University, Ankara, Turkey
  9. 9. Department of Pathology, The Johns Hopkins Hospital, 401 North Broadway Street, Weinberg 2242, Baltimore, 21231, MD, United States

Source: Virchows Archiv Published:2016


Abstract

Somatic activating mutations in the promoter of the telomerase reverse transcriptase (TERT) gene are the most common genetic alterations in urothelial carcinoma (UC) of the bladder and upper urinary tract. Little is known, however, about TERT-mutation status in the relatively uncommon but clinically aggressive micropapillary (MPC) variant. We evaluated the presence of TERT promoter mutations in MPC of the bladder and upper urinary tract. A retrospective search of our archives for MPC and UC with micropapillary features (2005–2014) was performed. All slides were reviewed to confirm the histologic diagnosis. Thirty-three specimens from 31 patients had FFPE blocks available for DNA analysis and were included in the study. Intratumoral areas of non-micropapillary histology were also evaluated when present. Samples were analyzed with Safe-SeqS, a sequencing error reduction technology, and sequenced using the Illumina MiSeq platform. TERT promoter mutations were detected in all specimens with pure MPC (18 of 18) and UC with focal micropapillary features (15 of 15). Similar to conventional UC, the predominant mutations identified occurred at positions −124 (C228T) (85 %) and −146 (C250T) (12 %) bp upstream of the TERT ATG start site. In heterogeneous tumors with focal variant histology, intratumoral concordant mutations were found in variant (MPC and non-MPC) and corresponding conventional UC. We found TERT promoter mutations, commonly found in conventional UC, to be frequently present in MPC. Our finding of concordant intratumoral mutational alterations in cases with focal variant histology lends support to the common oncogenesis origin of UC and its variant histology. © 2016, Springer-Verlag Berlin Heidelberg.